Where Does Sorrento Therapeutics Inc (SRNE) Stock Fall in the Biotechnology Field After It Is Up 50.00% This Week?

Sorrento Therapeutics Inc (SRNE) is around the bottom of the Biotechnology industry according to InvestorsObserver. SRNE received an overall rating of 26, which means that it scores higher than 26 percent of all stocks. Sorrento Therapeutics Inc also achieved a score of 14 in the Biotechnology industry, putting it above 14 percent of Biotechnology stocks. Biotechnology is ranked 46 out of the 148 industries.

SRNE has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on SRNE!

See Full SRNE Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 26 would rank higher than 26 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Sorrento Therapeutics Inc Stock Today?

Sorrento Therapeutics Inc (SRNE) stock is up 25.81% while the S&P 500 is lower by -1.93% as of 3:53 PM on Tuesday, Feb 21. SRNE has gained $0.08 from the previous closing price of $0.31 on volume of 172,454,253 shares. Over the past year the S&P 500 is down -7.07% while SRNE is lower by -85.97%. SRNE lost -$1.33 per share the over the last 12 months. Click Here to get the full Stock Report for Sorrento Therapeutics Inc stock.